Papers

2

Total Citations

10

H-Index

2

About

Dr. Zhongjin Yue is a pioneering urologic surgeon whose research focuses on advancing minimally-invasive surgical techniques for complex urologic cancers. His work centers on two critical areas: optimizing perioperative outcomes for bladder cancer patients undergoing robotic-assisted radical cystectomy (RARC) and expanding the boundaries of nephron-sparing surgery for highly complex renal tumors. In a landmark 2024 study, Dr. Yue provided the first comprehensive analysis of perioperative outcomes and continence following RARC with Mainz pouch II urinary diversion, demonstrating that this combined approach offers favorable functional results for bladder cancer patients—a contribution that has already garnered 7 citations and is reshaping clinical practice. His 2023 evidence-based analysis of minimally-invasive surgery for renal tumors with RENAL or PADUA scores ≥10 systematically evaluated perioperative, functional, and oncologic outcomes, establishing safety and efficacy benchmarks for treating these challenging cases (3 citations). Dr. Yue’s work directly addresses the gap between surgical innovation and real-world patient outcomes, providing urologists with actionable data to improve recovery and quality of life. His research is essential reading for surgeons seeking to master advanced robotic techniques in uro-oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Lanzhou University Second Hospital, Lanzhou University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago